Onego Bio produces Bioalbumen®, a bioidentical, animal-free egg protein made using precision fermentation with the patented Trichoderma reesei fungus. It offers a sustainable, scalable alternative to traditional egg protein for food manufacturers. Operating from Helsinki and San Diego, the company is pre-revenue but has strong interest from major food producers. Long term, Onego Bio aims to scale production, reduce environmental impact, and disrupt the $300 billion egg market.